0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > OX40

OX40

OX40 Molecule Information

Name:Tumor necrosis factor receptor superfamily member 4
Target Synonym:CD134?TNF Receptor Superfamily Member 4?OX40?Lymphoid Activation Antigene ACT35?OX40L receptor?TAX transcriptionally-activated glycoprotein 1 receptor?ACT35 antigen?TXGP1L?OX40 Cell Surface Antigen?IMD16?TNFRSF4
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:14
Lastest Research Phase:Phase ?

OX40 Protein Product ListCompare or Buy

Cat. No. Species Product Description Structure Purity Feature
OX0-M82E5 Mouse Biotinylated Mouse OX40 / TNFRSF4 / CD134 Protein, His Tag, Avi Tag (Avitag™)
OX0-M82E5-structure
OX0-M82E5-sds
OX0-M82E5-elisa_1
OX0-H5252 Human Human OX40 / TNFRSF4 / CD134 Protein, Mouse IgG2a Fc Tag, low endotoxin
OX0-H5252-structure
OX0-H5252-sds
OX0-H5252-elisa_1
OX0-M522b Marmoset Marmoset OX40 / TNFRSF4 / CD134 Protein, His Tag
OX0-M522b-structure
OX0-M522b-sds
OX0-M522b-elisa_1
TN4-H82E4 Human Biotinylated Human OX40 / TNFRSF4 / CD134 Protein, Avitag™,His Tag (recommended for biopanning)
TN4-H82E4-structure
TN4-H82E4-sds
TN4-H82E4-elisa_1
OX0-R5253 Rat Rat OX40 / TNFRSF4 / CD134 Protein, Fc Tag
OX0-R5253-structure
OX0-R5253-sds
OX0-R5254 Rabbit Rabbit OX40 / TNFRSF4 / CD134 Protein, Fc Tag
OX0-R5254-structure
OX0-R5254-sds
OX0-H82F7 Human Biotinylated Human OX40 Protein, Fc,Avitag™
OX0-H82F7-structure
OX0-H82F7-sds
OX0-H82F7-elisa_1
OX0-C5251 Rhesus macaque Rhesus macaque OX40 / TNFRSF4 / CD134 Protein, Fc Tag
OX0-C5251-structure
OX0-C5251-sds
OX0-C5251-elisa_1
OX0-C5220 Rhesus macaque Rhesus macaque OX40 / TNFRSF4 / CD134 Protein, His Tag
OX0-C5220-structure
OX0-C5220-sds
OX0-C5220-elisa_1
OX0-M5259 Mouse Mouse OX40 / TNFRSF4 / CD134 Protein, Fc Tag
OX0-M5259-structure
OX0-M5259-sds
OX0-M5259-elisa_1
OX0-M5228 Mouse Mouse OX40 / TNFRSF4 / CD134 Protein, His Tag
OX0-M5228-structure
OX0-M5228-sds
OX0-M5228-elisa_1
OX0-H5224 Human Human OX40 / TNFRSF4 / CD134 Protein, His Tag
OX0-H5224-structure
OX0-H5224-sds
OX0-H5224-elisa_1
OX0-H5255 Human Human OX40 / TNFRSF4 / CD134 Protein, Fc Tag
OX0-H5255-structure
OX0-H5255-sds
OX0-H5255-elisa_1

OX40 Molecule Synonym Name

TNFRSF4,OX40,CD134,OX40L receptor,ACT35,TXGP1L

OX40 Molecule Background

Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) is also known as ACT35 antigen, OX40L receptor, TAX transcriptionally-activated glycoprotein 1 receptor, CD antigen CD134, OX40. OX40 / TNFRSF4 contains four TNFR-Cys repeats. TNFRSF4 is receptor for TNFSF4 / OX40L / GP34 and can interacts with TRAF2, TRAF3 and TRAF5.

OX40 References

OX40 Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
INCAGN-1949 INCAGN-1949 Phase Ⅱ Agenus, Ludwig Institute for Cancer Research, Incyte Urogenital cancer, Renal cell carcinoma, Solid tumours Details
SL-279252 SL-279252 Phase Ⅰ Shattuck Labs Gastric adenocarcinoma, Non small cell lung cancer (NSCLC), Diffuse large B cell lymphoma, Renal cell carcinoma, Urothelial cancer, Solid tumours, Squamous cell carcinoma of head and neck cancer (SCCHN), Hodgkin lymphoma, Gastroesophageal junction adenocarcinoma, Melanoma Details
Efizonerimod alfa MEDI-6383,MEDI6383 Phase Ⅰ MedImmune Solid tumours Details
GSK3174998 GSK-3174998; GSK 3174998; GSK3174998 Phase Ⅱ GlaxoSmithKline Solid tumours, Head and neck cancer Details
PF-04518600 PF-04518600; PF-8600,PF04518600; PF8600 Phase Ⅱ Pfizer Solid tumours, Acute myeloid Leukemia (AML), Hepatocellular carcinoma (HCC), Clear cell renal cell cancer (ccRCC), Head and neck cancer, Melanoma Details
BMS-986178 (Bristol-Myers Squibb) BMS-986178 Phase Ⅱ Bristol-Myers Squibb Solid tumours Details
Recombinant human anti-OX40 monoclonal antibody (Livzon Group) Phase Ⅰ Livzon Pharmaceutical Group Cancer Details
MEDI-6469 MEDI-6469 Phase Ⅱ AgonOx, Providence Cancer Center, MedImmune Diffuse large B cell lymphoma, Prostate cancer, Breast cancer, Colorectal cancer, Head and neck cancer, Melanoma Details
Recombinant human anti-OX40 monoclonal antibody (Innovent Biologics) IBI-101,IBI101 Phase Ⅰ Innovent Biologics Cancer Details
KHK-4083 KHK-4083 Phase Ⅱ Kyowa Hakko Kirin Ulcerative colitis Details
ATOR-1015 ATOR-1015; ADC-1015 Phase Ⅰ Alligator Bioscience Solid tumours Details
Tavolimab MEDI-0562,MEDI0562 Phase Ⅱ MedImmune Ovarian cancer Details
GBR-830 GBR-830  Phase Ⅱ Glenmark Pharma Atopic dermatitis Details
Vonlerolizumab RO-7021608; MOXR-0916; RG-7888 Phase Ⅱ Genentech Solid tumours Details

This web search service is supported by Google Inc.

totop